tiprankstipranks
Trending News
More News >
PACS Group Inc (PACS)
NYSE:PACS
US Market

PACS Group Inc (PACS) AI Stock Analysis

Compare
230 Followers

Top Page

PACS

PACS Group Inc

(NYSE:PACS)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
$33.00
▼(-5.15% Downside)
PACS Group Inc. demonstrates strong growth and positive momentum, supported by strategic acquisitions and operational improvements. However, high leverage, low profitability, and recent executive changes pose risks. The stock's high valuation and potential overbought technical indicators warrant cautious optimism.
Positive Factors
Revenue Growth
The company's strong revenue growth indicates robust market demand and effective business strategies, supporting long-term expansion and stability.
Cash Generation
Improved cash generation enhances financial flexibility, enabling investment in growth opportunities and strengthening the company's financial position.
Strategic Acquisitions
Strategic acquisitions expand market presence and operational scale, providing potential for increased revenue and competitive advantage.
Negative Factors
High Leverage
High leverage can increase financial risk and limit flexibility, potentially impacting long-term financial health and operational capacity.
Low Profit Margins
Persistently low profit margins may hinder the company's ability to reinvest in growth and maintain competitive positioning over time.
Increased Service Costs
Rising service costs could pressure margins and profitability, challenging the company's ability to sustain financial performance.

PACS Group Inc (PACS) vs. SPDR S&P 500 ETF (SPY)

PACS Group Inc Business Overview & Revenue Model

Company DescriptionPACS Group Inc (PACS) is a technology-driven company that specializes in providing advanced solutions in data management and analytics across various sectors, including healthcare, finance, and logistics. The company focuses on developing innovative software applications and cloud-based services that enhance operational efficiency and decision-making for its clients. PACS's core products include data integration platforms, analytics tools, and customized enterprise solutions designed to streamline business processes and improve data accessibility.
How the Company Makes MoneyPACS Group Inc generates revenue primarily through the sale of software licenses, subscription services, and consulting fees. The company offers tiered pricing models for its software products, allowing clients to select packages that suit their specific needs, which contributes to a steady stream of recurring revenue. Additionally, PACS engages in strategic partnerships with key players in the technology and service industries, enhancing its product offerings and expanding its market reach. Consulting services related to implementation, customization, and ongoing support further bolster its revenue streams. The company also benefits from long-term contracts with clients in various sectors, ensuring stable income from ongoing service agreements.

PACS Group Inc Earnings Call Summary

Earnings Call Date:Nov 19, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 18, 2026
Earnings Call Sentiment Positive
The earnings call presented a strong performance in terms of revenue growth and successful integration of acquisitions. While there were notable improvements in occupancy and quality ratings, challenges remain with new facility occupancy rates and increased service costs. Overall, the highlights outweigh the lowlights, suggesting a positive outlook.
Q3-2025 Updates
Positive Updates
Record Revenue and Growth
PACS Group achieved record revenue and adjusted EBITDA for the first 9 months of 2025. Revenue for Q3 2025 was $1.3 billion, a 31% increase over the same period in the prior year. Year-to-date revenue reached $3.9 billion, a 36% increase over the same period in 2024.
Strong Occupancy Rates
Total occupancy across the portfolio stood at 89%, with mature facilities achieving 95% occupancy, up from 94% last year.
Successful Acquisitions and Integration
In the latter half of 2024, PACS Group acquired 94 facilities, significantly expanding their geographic footprint. The 2024 acquisitions increased their scale by adding over 8,700 new beds.
Improved CMS Quality Ratings
68.6% of PACS Group's skilled nursing portfolio is rated 4 or 5 stars based on CMS star ratings, highlighting the quality improvements across facilities.
Negative Updates
Challenges with New Facility Occupancy
New facilities acquired within the last 18 months show an occupancy rate of 81%, down from 83% in the prior year, reflecting challenges during the onboarding period.
Increased Costs of Services
Cost of services increased by 32% year-over-year, driven by investments in staffing and quality improvements. This increased cost aligns with their growth but could pressure margins.
Company Guidance
During PACS Group's third-quarter 2025 earnings call, guidance for the full year 2025 was provided, projecting annual revenue between $5.25 billion and $5.35 billion, a 30% increase over 2024. The company also anticipates adjusted EBITDA to range from $480 million to $490 million. Year-to-date, PACS reported $3.9 billion in revenue, marking a 36% rise from the previous year, with adjusted EBITDAR at $646.2 million and adjusted EBITDA at $363.0 million. The quarter's results included $1.3 billion in revenue, a 31% increase year-over-year, and a net income of $52.3 million. Diluted earnings per share for the quarter were reported at $0.32, while year-to-date was $0.80. The company highlighted strong occupancy rates, with mature facilities at 95% and newly acquired facilities at 81%. The call underscored PACS Group's strategic acquisitions, operational improvements, and disciplined growth strategy to capitalize on demographic trends and drive further growth through 2025.

PACS Group Inc Financial Statement Overview

Summary
PACS Group Inc. shows strong revenue growth and improved cash flow generation, which are positive indicators of financial health. However, the company faces challenges with low profitability margins and high leverage, which could pose risks if not managed effectively.
Income Statement
65
Positive
PACS Group Inc. has demonstrated strong revenue growth with a 113.39% increase in the latest year, indicating robust expansion. However, the net profit margin remains low at 1.36%, suggesting challenges in converting revenue into profit. The gross profit margin improved to 19.38%, reflecting better cost management. Despite these improvements, the EBIT margin is notably low, indicating potential inefficiencies in operational management.
Balance Sheet
50
Neutral
The balance sheet shows a high debt-to-equity ratio of 4.35, indicating significant leverage and potential financial risk. The return on equity has improved to 7.86%, suggesting better utilization of shareholder funds. However, the equity ratio remains low, highlighting a reliance on debt financing over equity.
Cash Flow
70
Positive
Cash flow analysis reveals a substantial improvement in free cash flow growth at 345.70%, showcasing enhanced cash generation capabilities. The operating cash flow to net income ratio is 0.38, indicating reasonable cash flow relative to earnings. The free cash flow to net income ratio of 0.82 suggests efficient conversion of earnings into cash.
BreakdownTTMDec 2024Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue5.14B4.09B3.11B2.42B
Gross Profit1.01B792.64M447.07M400.68M
EBITDA123.70M40.81M232.87M254.89M
Net Income169.04M55.76M112.87M150.50M
Balance Sheet
Total Assets5.63B5.24B3.51B2.46B
Cash, Cash Equivalents and Short-Term Investments355.67M157.67M73.42M66.12M
Total Debt3.22B3.09B2.85B1.93B
Total Liabilities4.75B4.53B3.41B2.39B
Stockholders Equity871.32M709.55M96.13M63.65M
Cash Flow
Free Cash Flow546.80M300.88M17.91M14.38M
Operating Cash Flow696.85M367.34M63.70M92.61M
Investing Cash Flow44.15M-442.68M-172.79M-75.32M
Financing Cash Flow-121.12M117.48M129.59M12.35M

PACS Group Inc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price34.79
Price Trends
50DMA
18.68
Positive
100DMA
15.13
Positive
200DMA
13.12
Positive
Market Momentum
MACD
4.59
Positive
RSI
81.28
Negative
STOCH
66.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PACS, the sentiment is Positive. The current price of 34.79 is above the 20-day moving average (MA) of 27.91, above the 50-day MA of 18.68, and above the 200-day MA of 13.12, indicating a bullish trend. The MACD of 4.59 indicates Positive momentum. The RSI at 81.28 is Negative, neither overbought nor oversold. The STOCH value of 66.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PACS.

PACS Group Inc Risk Analysis

PACS Group Inc disclosed 64 risk factors in its most recent earnings report. PACS Group Inc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

PACS Group Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$1.54B10.788.00%12.11%1.97%-35.20%
75
Outperform
$715.62M9.438.46%13.89%-8.32%-33.94%
66
Neutral
$4.82B29.6622.08%35.37%-37.58%
60
Neutral
$765.97M55.5212.49%37.01%
54
Neutral
$381.84M27.922.72%14.10%-2.38%-75.49%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PACS
PACS Group Inc
34.79
19.61
129.18%
TREE
Lendingtree
54.06
13.94
34.75%
PSBD
Palmer Square Capital BDC Inc.
12.09
-2.08
-14.68%
NCDL
Nuveen Churchill Direct Lending Corp.
14.40
-0.83
-5.45%
MSDL
Morgan Stanley Direct Lending Fund
17.34
-1.78
-9.31%
SUPX
Super X AI Technology
19.04
14.85
354.42%

PACS Group Inc Corporate Events

Delistings and Listing ChangesRegulatory Filings and Compliance
PACS Group Extends Forbearance Agreement to November 2025
Neutral
Nov 6, 2025

On August 13, 2025, PACS Group, Inc. entered into a Forbearance Agreement and Fifth Amendment to Credit Agreement with Truist Bank and other lenders, which was extended on October 30, 2025, to November 30, 2025. The company is also working to meet its SEC reporting obligations by November 19, 2025, to comply with NYSE requirements.

Delistings and Listing ChangesFinancial DisclosuresRegulatory Filings and Compliance
PACS Group Inc Receives NYSE Compliance Extension
Neutral
Sep 10, 2025

On September 9, 2025, PACS Group Inc. received an extension from the NYSE Listing Operations Committee to regain compliance with reporting requirements by November 19, 2025. The company has faced delays in filing several financial reports due to an independent investigation by its Audit Committee, and it is working to restate prior financial statements and complete delinquent filings to meet NYSE standards.

Executive/Board ChangesLegal Proceedings
PACS Group Inc Appoints Interim CFO Mark Hancock
Negative
Sep 8, 2025

On September 2, 2025, Derick Apt resigned as Chief Financial Officer of PACS Group Inc. following an investigation by the Audit Committee into allegations of policy violations related to accepting high-value items. In response to these findings, a separation agreement was reached, and the company has begun searching for a permanent CFO while enhancing its finance team. Mark Hancock, a co-founder and former CFO, was appointed as interim CFO on September 3, 2025. Hancock, who has extensive experience in finance and leadership roles within the company, will continue to serve as Executive Vice Chairman and a board director.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025